Recovery From Heart Failure: Microvascular Mechanisms

Area of Science:

• Cardiovascular Biology
• Regenerative Medicine
• Molecular Cardiology

Background:

• Heart failure (HF) is a major global health concern.
• Left ventricular assist devices (LVADs) bridge patients to heart transplantation and can improve cardiac function.
• The cellular mechanisms behind LVAD-induced cardiac recovery are not fully understood.

Purpose of the Study:

• To investigate the cellular and molecular changes in the heart following LVAD support.
• To identify the cellular origins of vascular repair during heart failure recovery.
• To elucidate the role of specific molecular pathways in mediating cardiac regeneration.

Main Methods:

• Analysis of myocardial tissues from HF patients pre- and post-LVAD implantation.
• Single-nucleus RNA sequencing to profile cellular changes.
• Murine model of HF recovery with lineage tracing.
• In vitro studies using patient-derived cardiac nonmyocyte cultures.
• Assessment of cardiac function, fibrosis, and vascular density.

Main Results:

• Post-LVAD hearts showed reduced fibrosis and increased capillary density.
• Fibroblast abundance correlated inversely with endothelial cell abundance, suggesting angiogenesis.
• Single-nucleus RNA sequencing revealed a fibroblast subset undergoing mesenchymal-to-endothelial transition.
• c-Myc was identified as a key regulator of this cell fate transition.
• Murine models recapitulated patient findings, demonstrating fibroblast-to-endothelial transition during HF recovery.

Conclusions:

• Heart failure recovery involves reduced fibrosis and enhanced microvascularization.
• A fibroblast-to-endothelial cell fate transition contributes to cardiac repair.
• The transcription factor c-Myc plays a crucial role in regulating this transition.
• These findings provide a mechanistic basis for developing regenerative therapies for heart failure.